Predicting DNA Damage

Premium

 

Researchers led by Rebecca Fry at MIT, who is now at the University of North Carolina School of Public Health, have discovered a gene expression signature that can predict how well cells will respond to a DNA damaging agent. Extending this basic work to the clinic could mean better predicting how patients will respond to chemotherapy. The scientists published their findings in the September 19 online edition of the Journal Genes and Development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.